Axa
GH icon

Axa’s Guardant Health GH Stock Holding History

Axa’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-138,656
Closed -$3.77M – 1135
2022
Q4 		$3.77M Sell
138,656
-114,088
-45% -$5.22M 0.01% 664
2022
Q3 		$13.6M Sell
252,744
-5,142
-2% -$264K 0.05% 363
2022
Q2 		$10.4M Sell
257,886
-3,969
-2% -$197K 0.04% 429
2022
Q1 		$17.3M Sell
261,855
-8,366
-3% -$573K 0.05% 388
2021
Q4 		$27M Buy
270,221
+7,021
+3% +$726K 0.07% 301
2021
Q3 		$32.9M Buy
263,200
+129,404
+97% +$15.4M 0.09% 249
2021
Q2 		$16.6M Buy
133,796
+34,335
+35% +$4.62M 0.05% 391
2021
Q1 		$15.2M Buy
99,461
+1,844
+2% +$279K 0.05% 406
2020
Q4 		$12.6M Buy
97,617
+3,936
+4% +$453K 0.04% 441
2020
Q3 		$10.5M Sell
93,681
-5,799
-6% -$530K 0.04% 446
2020
Q2 		$8.07M Buy
99,480
+14,904
+18% +$1.2M 0.03% 489
2020
Q1 		$5.89M Buy
+84,576
New +$6.49M 0.03% 481

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Axa's GH Position: Q1 2023 in Review

Axa sold out of Guardant Health (GH) in Q1 2023, closing a stake of 138,656 shares — an estimated $3.77M sold.

Axa first reported a position in GH in Q1 2020 and held it in 12 quarters. The position peaked at $32.9M in Q3 2021. 279 funds tracked by Wall St. Rank hold GH as of Q1 2023.

  • Axa reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
  • Axa sold 138,656 Guardant Health shares in Q1 2023, an estimated $3.77M.
  • Axa first reported a position in Guardant Health in Q1 2020 and held it in 12 quarters.
  • Axa's Guardant Health position peaked at $32.9M in Q3 2021.
  • 279 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on Axa's 13F filing for Q1 2023, filed 15 May 2023.